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Background: With about half a billion cases, of which nearly one million fatal ones, malaria constitutes one of the
major infectious diseases worldwide. A recently revived effort to eliminate the disease also focuses on IT resources
for its efficient control, which prominently includes the control of the mosquito vectors that transmit the
Plasmodium pathogens. As part of this effort, IDOMAL has been developed and it is continually being updated.
Findings: In addition to the improvement of IDOMAL’s structure and the correction of some inaccuracies, there
were some major subdomain additions such as a section on natural products and remedies, and the import, from
other, higher order ontologies, of several terms, which were merged with IDOMAL terms. Effort was put on
rendering IDOMAL fully compatible as an extension of IDO, the Infectious Disease Ontology. The reason for the
difficulties in fully reaching that target were the inherent differences between vector-borne diseases and “classical”
infectious diseases, which make it necessary to specifically adjust the ontology’s architecture in order to comprise
vectors and their populations.
Conclusions: In addition to a higher coverage of domain-specific terms and optimizing its usage by databases and
decision-support systems, the new version of IDOMAL described here allows for more cross-talk between it and
other ontologies, and in particular IDO. The malaria ontology is available for downloading at the OBO Foundry
(http://www.obofoundry.org/cgi-bin/detail.cgi?id=malaria_ontology) and the NCBO BioPortal (http://bioportal.
bioontology.org/ontologies/1311).
Keywords: Malaria, Vector borne disease, IDO, Remedies, OntologyFindings
Background
Although eradicated from most of the non-tropical re-
gions of the world since decades, malaria is still being
considered as one of the major scourges of mankind, af-
fecting hundreds of millions of people in the tropical re-
gions of the world [1]. Recent years have witnessed a
revival of the idea of eradicating the disease, although
this time the prevailing goal is that of elimination, rather
than to completely expunge it [2,3]. To achieve this ob-
jective emphasis has to be put on disease control, aiming
at both the disease as such (prevention, diagnosis and
treatment) and, most importantly, at vector control [1].
On both fronts, different measures have to be chosen
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reproduction in any medium, provided the ordevelopment, innovative strategies for vector control
and vector population monitoring, etc., have to be prom-
inently assisted by approaches based on Information
Technology (IT). It becomes clear that there is a need
for new effective tools that will be able to combine dif-
ferent, yet related datasets covering various aspects of
disease (e.g. epidemiological and entomological data,
intervention efforts, etc.). These tools encompass re-
sources such as smart databases (including decision sup-
port systems), enhanced bioinformatics software and
usage of technologies such as the Internet and mobile
telephony for the fast transfer of data. The latter is espe-
cially crucial, given that malaria usually strikes the
world’s poorest areas, in countries in which general in-
frastructures are often under-developed.
It is now established that ontologies help overcome
several difficulties encountered in the wide usage of IT
resources by achieving enhanced interoperability. This is
the reason why we decided to put emphasis on the de-
velopment of ontologies that cover the domains of both
vector borne diseases, including malaria, and the vectorsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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oped a series of ontologies [4] that describe the anatomy
of mosquitoes and ticks, mosquito insecticide resistance,
as well as malaria as the first disease in this category. It
was early on decided that the latter ontology, IDOMAL
[5], would be built as an extension to IDO, the Infec-
tious Disease Ontology [6]. The first version of
IDOMAL was made publicly available three years ago, at
a time when IDO was still at a very early stage of devel-
opment. This “wrong order” obviously led to some dis-
crepancies between the two ontologies, which would
have to be reconciled if IDOMAL is to be considered a
bona fide extension of IDO. It is particularly important
to achieve the status as early as possible, since we are in
the process of developing additional ontologies in the
domain of vector borne diseases such as, for example,
IDODEN, a yet unpublished ontology for Dengue fever
[7]. IDODEN follows the same architecture as IDOMAL,
something that proved to be extremely efficient in terms
of the ontology design. We therefore decided to restruc-
ture IDOMAL at this point in order to avoid major fu-
ture “repair” work on several ontologies. Here, we
describe both the changes introduced in IDOMAL for
this purpose, as well as several other changes that have
been made.
Updating IDOMAL
All significant changes introduced to IDOMAL are indi-
cated in Table 1. In total 222 terms were added, while
another 207 changes of different nature were performed.
All terms and relations that are included in the ontol-
ogies described here are in italics. The first piece of up-
date is the conversion of IDOMAL from the OBO
format to OWL. The advantages and shortcomings of
the one versus the other format are not to be discussed
here. Given, though, the increased spread of the OWL
format among bio-ontologies we decided to proceed
with the conversion, at the same time making both the
OBO and the OWL formatted versions available to the
community. We used the OBOtoOWL script that we
previously described [8] to achieve the conversion.Table 1 List of changes and corrections introduced in IDOMA
Update element Action
Non availability of IDOMAL in OWL Format Used OBOtoOW
Several terms lacked “is_a” paths to top Completed “is_
Multiple (11) root terms Fully adopted B
Availability of terms in other ontologies Imported (merg
“Missing” terms 146 terms adde
Absence of terms relating to natural products/remedies 76 terms added
Minor problems (typos, individual terms, definitions) Edited/ comple
Discrepancies with IDOThe next change introduced to IDOMAL could be
called technical since it concerned the editing of the
ontology in order to make sure that all terms of the
ontology have complete is_a paths to the root, which,
now, in accordance to BFO (Basic Formal Ontology)
[9-11] is entity. Therefore the term role which was one
of many root-level terms in previous versions, now took
its proper place and is to be found under realizable en-
tity, which is a specifically dependent continuant, which
is a dependent continuant, which is a continuant, which
is an entity – the root term of BFO. Furthermore, condi-
tion, which was also a top-level term, is now a sibling of
role, in accordance to the BFO 1.0 specification [9-11].
Finally, we corrected typos that were found, and added a
small number of terms that had either missed our atten-
tion or their inclusion was deemed necessary given the
latest developments in malaria research.
A further major addition to IDOMAL concerns the in-
clusion of terms from the sub-domain of natural remed-
ies and medicinal plants. Chemotherapy of malaria has
been increasingly hindered by the development of resist-
ance of Plasmodium parasites against antimalarial drugs
[12]. The search for novel antimalarials, therefore, has
now also turned its attention to traditional remedies, in
particular natural products derived from plants. It
should be stressed that, currently, one such product and
its derivatives (artemisinins), against which widespread
resistance had not been developed, are now under such
risk [13]. To cover the domain we used, mostly, a hand-
book [14] that fully covers the domain. We should
underline the fact that we concentrated, obviously, on
terms that described substances and procedures for
which a certain degree of efficacy had been previously
shown. Similar to what is true for “conventional” anti-
malarials, we do not consider the terms included as
complete, and we are planning to perform more addi-
tions if necessary.
In addition to this important addition we also decided
to perform a wide “exchange” of terms. The decision
was taken based on the idea that in the now rapidly
expanding field of bio-ontologies the same term is oftenL
Comments
L script to generate Both versions publically available
a” paths for all terms
FO hierarchy to top-level entity is now the single root term.
ed) terms from other ontologies
d
(included in those above)
ted
See Table 2 for details
Topalis et al. Journal of Biomedical Semantics 2013, 4:16 Page 3 of 6
http://www.jbiomedsem.com/content/4/1/16defined differently, and is also linked with is_a relations
to terms that are different. For example, querying the
Bioportal [15] one finds that the term symptom is now
described in 15 distinct ontologies. Interestingly, IDO in-
cludes symptom as a quality and has no children terms,
the Ontology for General Medical Science (OGMS) [16]
has entity as its parent and only lists one child (pain)
while, finally, the Influenza ontology (FLU) [17] also has
entity as the parent of symptom (also imported from
OGMS) and has 8 children listed that, though, do not
include pain. It should be noted that FLU is an exten-
sion of IDO. In IDOMAL, symptom (with a large num-
ber of children) is linked to condition of the malaria
host, which is obviously a child of condition. We decided
to replace all children of symptom with those listed by
the Symptom Ontology (SYMP) [18], in which symptom
is the root. By term replacing we actually mean the mer-
ging of the terms from SYMP to those in IDOMAL.
Merging, instead of replacing leaves both IDs intact
within IDOMAL, and therefore if somebody has already
been using IDOMAL there will be no need to perform
any changes in the software that uses the ontology.
The choice of SYMP was made purely on the fact
that alternatives such as OGMS do not list the terms
that we needed. Finally, we should state at this point that
IDO is using the symptom term imported from OGMS
(see below).
IDOMAL and IDO
As mentioned earlier, due to the timing of development
of the two ontologies the published version of IDOMAL
has some features that make it difficult, as such, to be
called an extension of IDO in the latter’s present form.
The example stated above, i.e. the term symptom being
imported from two different ontologies, exemplifies this
problem while, at the same time, it also shows that the
differences are not necessarily irreconcilable: the easiest
solution for this kind of discrepancy would be to simply
merge the two terms. There are several more examples
of how some differences may be eliminated. Table 2 lists
these, showing in addition the actions taken or to be
taken. For example, while antiparasitic drug is a role in
IDOMAL, a term antiparasitic disposition is found in
IDO, defining antiparasitic material entity as entity,
which bears antiparasitic disposition (IDO contains dis-
positions such as antibacterial, antifungal, antiparasitic,
antimicrobial, antiviral). We could easily reconcile the
difference by accepting that antimalarial drug in
IDOMAL is a role borne by a material entity which has
antiparasitic disposition and is given to a patient to treat
malaria. This would follow the example set in IDO by
antiseptic role (definition: A role borne by a material en-
tity in virtue of the fact that it has an antimicrobial dis-
position and is applied to an anatomical entity of a livingorganism). There are a few more cases of discrepancy
between the two ontologies and for some of them we
have decided to adopt the IDO point of view. For ex-
ample, endemicity that was a disposition in IDOMAL
will be changed to quality of a population, and so
will be the terms holoendemicity, hypoendemicity and
mesoendemicity, which are absent from IDO. We have
also changed resistance from quality to disposition; al-
though a good case was made for the fact that resistance
is a disposition [19], we should nevertheless state here
that resistance is in most, if not all cases a genetic
phenotype. And without going into further discussions,
we simply state that phenotypes are usually considered
to be quality, possibly because of the fact that several
of them are visible (e.g. white eyes, ectopic expres-
sion, etc.). Finally, habitat, a spatial region so far in
IDOMAL, has been changed to site like in IDO.
What also had to be changed to fit the present onto-
logical representation is to define breeding site as a
role carried by material entity (i.e. site).
In spite of the changes made, a series of issues remain
that haven’t yet been resolved. Some of them, in our
opinion, are relatively secondary and they could be re-
solved easily. For example, terms such as treatment and
refractoriness which we deem to be necessary for an
ontology of vector borne diseases could be carried again
by IDO, from which they were obsoleted some time ago.
The remaining open issues are due to the distinctive
properties of vector borne diseases. These infections are
characterized by the fact that they arise through the bio-
logical interactions between three organisms (patient/
host, vector and pathogen), rather than only two as is
common in the vast majority of infectious diseases.
Thus, an ontology such as IDOMAL has to capture all
three organisms, as well as prominently include terms
on the respective populations. For example, control of
malaria, eventually leading, perhaps, to its elimination, is
predominantly based on vector control. This involves
measures aimed, for example, at reducing mosquito pop-
ulations, possibly using genetic approaches [20] or, as
may be the case in the future if planned strategies suc-
ceed, at replacing vector populations with others that
will simply not be able to transmit the pathogen [21].
Both IDO and IDOMAL use the BFO [9-11] as an
upper level ontology. IDO would then describe the
infectious disease domain, while IDOMAL would ideally
be placed below it. The current structure of IDO,
though, does not allow for a full deployment of the mal-
aria domain. IDOMAL has separated several classes of
terms in three main “groups” namely the patient/host,
the vector and the pathogen or, to be more precise, into
six groups since populations are “treated” separately.
The reason for this is obvious: many terms apply to both
patient/host and vector (both being metazoan). Similarly,
Table 2 Differences between IDO and IDOMAL and steps (to be) taken to unify the ontologies
IDO-IDOMAL “comparison” Action Comments
IDO: symptom imported from OGMS, no children
IDOMAL: native term, 39 children Imported/merged terms from
Symptom Ontology
IDO: endemicity is quality of a population
IDOMAL: endemicity is disposition Changed in IDOMAL, now as in IDO
IDO: habitat is site (material entity)
IDOMAL: habitat is spatial region Changed in IDOMAL, now as in IDO
IDO: breeding site absent
IDOMAL: Anopheles breeding site is a role Changed to Anopheles breeding
site role born by site (material entity)
IDO: epidemiological types [of an infectious
disease] absent
IDOMAL: epidemiological types of malaria present Discuss with IDO developers Needed in IDOMAL
IDO: antiparasitic material entity is material entity
bearing antiparasitic disposition
IDOMAL: antiparasitic drug is a role. Issue solved in IDOMAL: antimalarial
drug is a role born by a material entity
which has antiparasitic disposition
Similar for antibiotic role/ disposition, etc.
IDO: resistance is a disposition
IDOMAL: resistance is quality (of (vector population) Changed in IDOMAL, now as in IDO
IDO: infection is a material entity
IDOMAL: infection is not present; infectious disposition
is not present
No action needed Terms are not needed in IDOMAL
IDO: vector competence is not present
IDOMAL: vector competence is present Discuss with IDO developers Needed in IDOMAL
IDO: infectious disease control is absent
IDOMAL: malaria control is present Discuss with IDO developers Needed in IDOMAL
IDO: No terms for decision support systems, [disease]
and vector control, intervention methods
IDOMAL: Corresponding terms present Discuss with IDO developers Needed in IDOMAL
IDO: refractoriness is obsolete term
IDOMAL: refractoriness is present Discuss with IDO developers Needed in IDOMAL
IDO: treatment is obsolete term in IDO
IDOMAL: treatment is present Discuss with IDO developers Needed in IDOMAL
IDO: holoendemicity / hypoendemicity / mesoendemicity
are missing
IDOMAL: terms are present Discuss with IDO developers Needed in IDOMAL
IDO: quality of infectious disease is absent
IDOMAL: quality of malaria is present Discuss with IDO developers Needed in IDOMAL, acts as a placeholder
for terms relating to malaria-specific
interventions.
IDO: process of infectious disease is absent
IDOMAL: process of malaria is present Discuss with IDO developers
IDO: no differentiation between host/patient and
pathogen
IDOMAL: differentiates between host/patient, vector
and pathogen
Discuss with IDO developers Needed in IDOMAL, coverage of physiological
and pathophysiological processes occurring
in host and/or vector and/or parasite.
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several terms are specific for populations, rather than in-
dividuals; this is especially true for vector control.
Another problem that is not yet resolved is how to
list in a grouped, ontologically correct form terms
such as pathogen specific form of malaria and epidemio-
logical type of malaria. A solution could be to create
sub-ontologies for each one of the different forms of
malaria (i.e. for P. falciparum, P. malariae, P. ovale and
P. vivax); we consider this to be impractical in several
obvious aspects. For the time being we keep the prob-
lematic class quality of malaria and we’ll aim at finding
an appropriate way to describe these features in collab-
oration with the IDO consortium. The class process of
malaria, thus, groups a series of physiological and
pathophysiological processes occurring in the patient/
host and/or the parasite. Finally, IDOMAL has no place-
holders for vector-specific processes (e.g. host seeking)
or qualities (e.g. vector competence). Of course, all of
these terms could be listed as direct children of process
and quality, but we think that a more detailed classifi-
cation would benefit the users of the ontology and,
especially, would make it easier to design other ontol-
ogies for vector-borne diseases. A similar consideration
is valid for malaria prevention and vector control, terms
that need to be included, and are now under the “place
holder” process of malaria. It should be noted here that
recently the Vector Surveillance and Management
Ontology (VSMO) was published that covers the do-
main of vector control [22]. This development may
make it easier to find a partial solution to the last men-
tioned problem.
Conclusions
It was not unexpected that IDOMAL had to undergo
several updates, partial revisions and expansion during
the three years after it was published, which all are sum-
marized in this report. Not only is it legitimate to always
try to obtain a better “product”, but also some of the
changes are dictated by the needs of the community (e.g.
remedies and natural products) or recent developments
in the field. As mentioned in the beginning, improved
IT tools are becoming indispensable, especially as high
throughput technology develops and provides more data.
In the case of malaria and other vector borne diseases,
this evolution is obvious. Only about ten years after the
determination of the genome sequence of Anopheles
gambiae [23] tens of genomes of different vectors have
become available [24]. Although so far genes are usually
only annotated with GO terms [25], the day is not
far when they, and other data in genomic/biological
databases, will also be annotated with ontological
terms describing these domains, such as, for example,
VectorBase, the database that covers arthropod diseasevectors [26]. Moreover novel IT tools such as decision
support systems are already making use of ontologies
[27] and, even more, tools are planned that will be able
to direct information to and from ontologies and data
holders [28]. In the domain of vector-borne diseases,
IDOMAL and MIRO, an ontology of Mosquito Insecti-
cide Resistance [29] that has now been fully integrated
in IDOMAL, are used by newly developed Decision Sup-
port Systems for vector-borne diseases [30,31]. Further-
more, VSMO also uses a several terms that have been
imported from IDOMAL [22]. It becomes clear that the
availability of all the new, open bio-medical ontologies
provides ways to achieve enhanced interoperability be-
tween databases and to expand the title of the original
publication of the Gene Ontology [32] to “tools for the
unification of bio-medical sciences”.
N.B. Both IDOMAL versions are available for
downloading: the OBO version is at the OBO Foundry
and at the NCBO BioPortal, while the OWL version is avail-
able at: http://anobase.vectorbase.org/idomal/.
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